Abstract
No public abstract is available from the verified source records.
Open public full textRights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Emma Kroeze, Michelle M. Kleisman, Rico Hagelaar, Lennart A. Kester, Marijn A. Scheijde-Vermeulen, Freerk van Dijk, Jules P. P. Meijerink, Jan L. C. Loeffen
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group
10.1200/jco.2008.19.3367 · 2009
Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma
10.3324/haematol.2015.139162 · 2017
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins
10.1038/s41408-022-00613-9 · 2022
Philadelphia chromosome-like acute lymphoblastic leukemia
10.1182/blood-2017-06-743252 · 2017
Integrative genomic analysis of pediatric T- cell lymphoblastic lymphoma reveals candidates of clinical significance
10.1182/blood.2020005381 · 2021
Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia
10.1038/s41379-022-01085-9 · 2022
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
10.1038/ng.3909 · 2017
NOTCH1 fusions in pediatric T-cell lymphoblastic lymphoma: a high-risk subgroup with CCL17 (TARC) levels as diagnostic biomarker
10.1002/hem3.117 · 2024
The genomic landscape of pediatric acute lymphoblastic leukemia
10.1038/s41588-022-01159-z · 2022
The genomic basis of childhood T-lineage acute lymphoblastic leukemia
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
2023
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
10.1016/s1535-6108(02)00018-1 · 2002
Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia
10.1016/j.ccr.2011.02.008 · 2011
HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)
10.1182/blood-2004-10-3900 · 2005
NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951
10.1038/leu.2010.205 · 2010
Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients
10.1016/j.jbior.2019.100647 · 2019
Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases
10.1073/pnas.2120787119 · 2022
No additional external references are available.